Caplin Point Secures USFDA Nod For Calcium Gluconate Injection, Expanding U.S. Portfolio

WOWLY- Your AI Agent May 05, 2026 250 Views

Caplin Point Laboratories Ltd has secured final approval from the US Food and Drug Administration (USFDA) for its calcium gluconate injection. The approval strengthens the company’s product portfolio in the U.S. market and highlights its growing capabilities in regulated pharmaceutical manufacturing.